Cargando…

Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis

Proteoglycans are promising therapeutic targets in Multiple Sclerosis (MS), because they regulate many aspects of the immune response. This was studied using surfen, an agent that binds both heparan sulphate proteoglycans (HSPGs) and chondroitin sulphate proteoglycans (CSPGs). Initial cell culture w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warford, Jordan R., Lamport, Anna-Claire, Clements, Derek R., Malone, Alicia, Kennedy, Barry E., Kim, Youra, Gujar, Shashi A., Hoskin, David W., Easton, Alexander S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755315/ https://www.ncbi.nlm.nih.gov/pubmed/29301568 http://dx.doi.org/10.1186/s40478-017-0506-9

Ejemplares similares

Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
por: Alavi Naini, Seyedeh Maryam, et al.
Publicado: (2018)

Correction to: Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
por: Naini, Seyedeh Maryam Alavi, et al.
Publicado: (2020)

Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy
por: Kim, Youra, et al.
Publicado: (2015)

Murine Experimental Autoimmune Encephalomyelitis Is Diminished by Treatment with the Angiogenesis Inhibitors B20-4.1.1 and Angiostatin (K1-3)
por: MacMillan, Carolyn J., et al.
Publicado: (2014)

An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination
por: Keough, Michael B., et al.
Publicado: (2016)

Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines
por: Holay, Namit, et al.
Publicado: (2017)

Remyelination In Multiple Sclerosis
por: Chari, Divya M.
Publicado: (2007)

Repurposing CD8(+) T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?
por: Gujar, Shashi, et al.
Publicado: (2020)

Remyelination Therapy in Multiple Sclerosis
por: Harlow, Danielle E., et al.
Publicado: (2015)

Promoting remyelination in multiple sclerosis
por: Cunniffe, Nick, et al.
Publicado: (2019)

TRPM2 ion channel promotes gastric cancer migration, invasion and tumor growth through the AKT signaling pathway
por: Almasi, Shekoufeh, et al.
Publicado: (2019)

Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses
por: Gujar, Shashi A, et al.
Publicado: (2014)

Quantitative Temporal in Vivo Proteomics Deciphers the Transition of Virus-Driven Myeloid Cells into M2 Macrophages
por: Clements, Derek R., et al.
Publicado: (2017)

After virus exposure, early bystander naïve CD8 T cell activation relies on NAD(+) salvage metabolism
por: Holay, Namit, et al.
Publicado: (2023)

Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination
por: Podbielska, Maria, et al.
Publicado: (2013)

Remyelination therapy goes to trial for multiple sclerosis
por: Brugarolas, Pedro, et al.
Publicado: (2014)

Promoting Remyelination in Multiple Sclerosis—Recent Advances
por: Jolanda Münzel, E., et al.
Publicado: (2013)

Imaging outcomes for trials of remyelination in multiple sclerosis
por: Mallik, Shahrukh, et al.
Publicado: (2014)

The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis
por: You, Yuyi, et al.
Publicado: (2018)

The Molecular Basis for Remyelination Failure in Multiple Sclerosis
por: Gruchot, Joel, et al.
Publicado: (2019)

Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination
por: Correale, Jorge, et al.
Publicado: (2022)

Remyelination in Multiple Sclerosis: Findings in the Cuprizone Model
por: Leo, Heinig, et al.
Publicado: (2022)

Mechanisms of Demyelination and Remyelination Strategies for Multiple Sclerosis
por: Zhao, Xinda, et al.
Publicado: (2023)

Reovirus in cancer therapy: an evidence-based review
por: Clements, Derek, et al.
Publicado: (2014)

Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities
por: Kim, Youra, et al.
Publicado: (2021)

Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis
por: Brown, Robert A., et al.
Publicado: (2014)

Erratum to: Promoting Remyelination in Multiple Sclerosis—Recent Advances
por: Münzel, E. Jolanda, et al.
Publicado: (2013)

Dynamic Imaging of Individual Remyelination Profiles in Multiple Sclerosis
por: Bodini, Benedetta, et al.
Publicado: (2016)

Remyelination in multiple sclerosis from the miRNA perspective
por: Maciak, Karina, et al.
Publicado: (2023)

TMEM10 Promotes Oligodendrocyte Differentiation and is Expressed by Oligodendrocytes in Human Remyelinating Multiple Sclerosis Plaques
por: de Faria, Omar, et al.
Publicado: (2019)

Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
por: Al Nimer, Faiez, et al.
Publicado: (2016)

Correlated Heterospectral Lipidomics for Biomolecular Profiling of Remyelination in Multiple Sclerosis
por: Bergholt, Mads S., et al.
Publicado: (2017)

Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis
por: Gharagozloo, Marjan, et al.
Publicado: (2022)

Remyelination varies between and within lesions in multiple sclerosis following bexarotene
por: Brown, J. William L., et al.
Publicado: (2022)

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
por: Keough, Michael B., et al.
Publicado: (2015)

Remyelination Induced by a DNA Aptamer in a Mouse Model of Multiple Sclerosis
por: Nastasijevic, Branislav, et al.
Publicado: (2012)

Correcting gut dysbiosis can ameliorate inflammation and promote remyelination in multiple sclerosis – Commentary
por: Hohlfeld, R
Publicado: (2021)

Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination
por: Schultz, Verena, et al.
Publicado: (2017)

The Role of Molecular Imaging as a Marker of Remyelination and Repair in Multiple Sclerosis
por: Ben-Shalom, Ido, et al.
Publicado: (2021)

Remyelination Improves Voiding Dysfunction in a Mouse Model of Multiple Sclerosis
por: Ramasamy, Ramalakshmi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2qbeev6rs57ukgn2j20qmfb1rn